Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Total 13F shares
-
7,361,043
-
Share change
-
+56,525
-
Total reported value
-
$213,798,867
-
Put/Call ratio
-
64%
-
Price per share
-
$29.04
-
Number of holders
-
109
-
Value change
-
+$1,986,104
-
Number of buys
-
50
-
Number of sells
-
51
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q4 2020
As of 31 Dec 2020 ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) had 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,361,043 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, GOLDMAN SACHS GROUP INC, INVESTMENT COUNSELORS OF MARYLAND LLC, THOMPSON SIEGEL & WALMSLEY LLC, STATE STREET CORP, FEDERATED HERMES, INC., AMERIPRISE FINANCIAL INC, and Russell Investments Group, Ltd..
This table shows 109 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.